Bliss GVS Pharma chairman and AGM
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹680.90.
30 Oct: open ₹660.00, high ₹670.00, low ₹646.90
- Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,885 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.71
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.23%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,45,760
Bliss GVS Pharma's chairperson is Nandkumar Kashinath Chodankar, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 15 Jul 2026.
Bliss GVS Pharma board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonNandkumar Kashinath Chodankar
- Company Secretary and Compliance OfficerMs. Aditi Bhatt
8 directors4 independent4 non-executive
- Nandkumar Kashinath Chodankar · ChairpersonIndependent · joined Jun 2024 · reappointed Jun 2024 · 27 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Deepak Rameshchandra ShahIndependent · joined Apr 2026 · reappointed Apr 2026 · 5 months as independent · 4 listed boards · 3 as independent · 5 committee seats, 3 as chair
- Vijayanarayanan MahadevanIndependent · joined Apr 2026 · reappointed Apr 2026 · 5 months as independent · 1 listed board · 1 as independent
- Shilpa Vinodkumar BhatiaIndependent · joined Feb 2020 · reappointed Feb 2025 · 79 months as independent · 3 listed boards · 3 as independent · 3 committee seats
- Santosh Laxman ParabNon-executive · joined Jul 2026 · reappointed Jul 2026 · 1 listed board
- Hetul Krishnakant MehtaNon-executive · joined Sep 2026 · reappointed Sep 2026 · 1 listed board
- Amar Dilip ShahNon-executive · joined Sep 2026 · reappointed Sep 2026 · 1 listed board
- Pramod Badrinarayan KasatNon-executive · joined Sep 2026 · reappointed Sep 2026 · 5 listed boards · 4 as independent · 4 committee seats, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
4 directors who left
- Narsimha Shibroor Kamath, left 28 Sep 2026: Others
- Shruti Vishal Rao, left 10 Feb 2026: Others
- Vibha Gagan Sharman, left 10 Feb 2026: Others
- Gagan Harsh Sharma, left 6 Nov 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 28 Sep 20266 of 6 present4 independent · 46 days in between
- 12 Aug 20266 of 6 present4 independent · 39 days in between
- 3 Jul 20265 of 5 present4 independent · 40 days in between
- 23 May 20265 of 5 present4 independent · 10 days in between
1 earlier meeting
- 12 May 20265 of 5 present4 independent
Audit Committee
Chair Deepak Rameshchandra Shah
Nandkumar Kashinath Chodankar, Shilpa Vinodkumar Bhatia
- 12 Aug 20264 of 4 present3 independent · 91 days in between
- 12 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Vijayanarayanan Mahadevan
Nandkumar Kashinath Chodankar, Shilpa Vinodkumar Bhatia
- 28 Sep 20263 of 3 present3 independent · 46 days in between
- 12 Aug 20263 of 3 present3 independent · 39 days in between
- 3 Jul 20263 of 3 present3 independent · 51 days in between
- 12 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair Nandkumar Kashinath Chodankar
Shilpa Vinodkumar Bhatia
- 12 May 20263 of 3 present2 independent
Risk Management Committee
Chair Shilpa Vinodkumar Bhatia
Deepak Sawant
- 22 Jul 20262 of 4 present1 independent · 70 days in between
Corporate Social Responsibility Committee
Chair Nandkumar Kashinath Chodankar
Shilpa Vinodkumar Bhatia
- 12 May 20263 of 3 present2 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Kalyaniwala & Mistry LLPPeer-review certificate valid to Jul 2027
1 earlier auditor
- M/s Kalyaniwalla & Mistry LLPNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Bliss GVS Pharma AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Bliss GVS Pharma dividend history
Postal ballot, 19 Sep 2026
46,226 shareholders on the register on 14 Aug 2026; votes counted by Mr.Vijay Yadav / AVS & Associates.The company's voting result
- APPOINTMENT OF MR. SANTOSH PARAB (DIN: 01622988) AS A DIRECTOR IN THE CAPACITY OF NON-EXECUTIVE NON-INDEPENDENT DIRECTOR OF THE COMPANY.Ordinary97.04% for2.96% against
Against: promoters 0.00% · institutions 15.53% · other public 0.00%
Turnout: all 58.66% · promoters 87.36% · institutions 69.98% · other public 34.56%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 15 Jul 2026, 3 resolutions
47,336 shareholders on the register on 8 Jul 2026; present: 2 promoters and 70 others; votes counted by Mr. Vijay Yadav / AVS & Associates.The company's voting result
- Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the AuditorsOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.04% · other public 0.00%
Turnout: all 61.66% · promoters 99.98% · institutions 36.02% · other public 42.90%
- Declaration of Final Dividend of 100% i.e. ₹ 1.00 per equity share on face value of ₹ 1/- each for the financial year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.67% · promoters 99.98% · institutions 36.08% · other public 42.90%
- Re-Appointment of Mr. Narsimha Shibroor Kamath (DIN: 00140593) as a Managing Director & CEO, liable to retire by rotation, who has offered himself for re-appointment.OrdinaryPromoters have an interest in it97.68% for2.32% against
Against: promoters 0.00% · institutions 14.45% · other public 0.00%
Turnout: all 61.67% · promoters 99.98% · institutions 55.97% · other public 35.44%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 9 May 2026, 2 resolutions
45,804 shareholders on the register on 7 Apr 2026; votes counted by Mr.Vijay Yadav / AVS & Associates.
- APPOINTMENT OF MR. VIJAYANARAYANAN MAHADEVAN (DIN: 06639177) AS A DIRECTOR IN THE CAPACITY OF NON-EXECUTIVE AND INDEPENDENT DIRECTOR OF THE COMPANYFOR A TERM OF FIVE YEARSSpecial99.72% for0.28% against
Against: promoters 0.00% · institutions 5.90% · other public 0.00%
Turnout: all 49.14% · promoters 92.45% · institutions 15.77% · other public 28.30%
- APPOINTMENT OF MR. DEEPAK RAMESHCHANDRA SHAH (DIN: 06954206) AS A DIRECTOR IN THECAPACITY OF NON-EXECUTIVE AND INDEPENDENT DIRECTOR OF THE COMPANYFOR A TERM OF FIVE YEARSSpecial99.72% for0.28% against
Against: promoters 0.00% · institutions 5.90% · other public 0.01%
Turnout: all 49.14% · promoters 92.45% · institutions 15.77% · other public 28.30%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 29 Jan 2026, 1 resolution
44,167 shareholders on the register on 26 Dec 2025; votes counted by Mr. Vijay Yadav / AVS & Associates.The company's voting result
- Appointment of Mr. Narsimha Shibroor Kamath (DIN:00140593) as ‘Director’ in the capacity of ‘Managing Director’ of the company.SpecialPromoters have an interest in it99.90% for0.10% against
Against: promoters 0.00% · institutions 0.00% · other public 0.41%
Turnout: all 60.21% · promoters 99.33% · institutions 48.17% · other public 34.47%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 31 Jul 2025, 4 resolutions
46,979 shareholders on the register on 24 Jul 2025; present: 4 promoters and 91 others; votes counted by Mr. Vijay Yadav / AVS & Associates.The company's voting result
- Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and the Auditors thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 58.21% · promoters 99.83% · institutions 45.86% · other public 30.95%
- Declaration of Final Dividend of 50 percent i.e. Rs. 0.50 paisa per equity share on face value of Rs. 1 each for the financial year ended March 31, 2025.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 58.22% · promoters 99.83% · institutions 45.91% · other public 30.95%
- Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment.OrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.02% · other public 0.01%
Turnout: all 55.78% · promoters 92.94% · institutions 45.91% · other public 30.95%
- Appointment of Messers. AVS & Associates, Company Secretaries as Secretarial Auditors of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 58.22% · promoters 99.83% · institutions 45.91% · other public 30.95%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 11 Jun 2025, 2 resolutions
50,199 shareholders on the register on 9 May 2025; votes counted by Mr. Vijay Yadav / AVS & Associates.
- Approval of the issuance of sweat equity shares to Mr. Gagan Harsh Sharma (DIN: 07939421), Managing Director of the CompanySpecialNot passedRecorded as not passed although most votes were for it; no reason is givenPromoters have an interest in it70.87% for29.13% against
Against: promoters 0.00% · institutions 84.41% · other public 2.05%
Turnout: all 26.44% · promoters 0.00% · institutions 44.56% · other public 39.26%
- Approval of the issuance of sweat equity shares to Mr. Vishal Vijay Rao, Vice-President of the CompanySpecialNot passedRecorded as not passed although most votes were for it; no reason is givenPromoters have an interest in it70.90% for29.10% against
Against: promoters 0.00% · institutions 84.41% · other public 2.00%
Turnout: all 26.44% · promoters 0.00% · institutions 44.56% · other public 39.26%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 25 Jul 2024, 10 resolutions
Present: 119 promoters and 3 others.
- Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2024 together with the reports of the Board of Directors and the Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 56.48% · promoters 100.00% · institutions 36.49% · other public 31.75%
- Declaration of Final Dividend of 50% i.e. Re. 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2024.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%
- Re-Appointment of Mrs. Shruti Vishal Rao (DIN: 00731501) as a Director, liable to retire by rotation, who has offered herself for reappointmentOrdinaryPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%
- Appointment of Dr. Nandkumar Kashinath Chodankar (DIN: 02736718) as an Independent Director of the CompanySpecial99.98% for0.02% against
Against: promoters 0.00% · institutions 0.15% · other public 0.05%
Turnout: all 49.91% · promoters 100.00% · institutions 2.85% · other public 31.75%
- Re-appointment of Mr. Gagan Harsh Sharma (DIN: 07939421) as a Managing Director of the CompanySpecialPromoters have an interest in it87.35% for12.65% against
Against: promoters 0.00% · institutions 100.00% · other public 0.10%
Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%
- Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Whole-Time Director of the CompanySpecialPromoters have an interest in it88.35% for11.65% against
Against: promoters 0.00% · institutions 92.20% · other public 0.02%
Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%
- Re-appointment of Mrs. Shruti Vishal Rao (DIN: 00731501) as a Whole-Time Director of the CompanySpecialPromoters have an interest in it88.35% for11.65% against
Against: promoters 0.00% · institutions 92.20% · other public 0.02%
Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%
- Re-appointment of Ms. Shilpa Bhatia (DIN: 08695595) as an Independent Director of the CompanySpecial99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%
- Re-appointment of Mr. Vishal Vijay Rao as a VicePresident of the Company, a relative of Directors holding office or place of profit in the CompanySpecialPromoters have an interest in it99.06% for0.94% against
Against: promoters 0.00% · institutions 7.40% · other public 0.04%
Turnout: all 56.49% · promoters 100.00% · institutions 36.54% · other public 31.75%
- Approval for Material Related Party Transaction(s) with Greenlife Pharmaceuticals LimitedOrdinaryPromoters have an interest in it69.08% for30.92% against
Against: promoters 0.00% · institutions 92.20% · other public 0.72%
Turnout: all 21.60% · promoters 0.00% · institutions 36.54% · other public 31.72%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 19 Jul 2023, 4 resolutions
Present: 2 promoters and 64 others.
- doption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon.Ordinary87.54% for12.46% against
Against: promoters 0.00% · institutions 70.70% · other public 0.00%
Turnout: all 53.14% · promoters 99.98% · institutions 40.45% · other public 20.75%
- Declaration of Final Dividend of 50% i.e. ₹ 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2023.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 53.16% · promoters 99.98% · institutions 40.52% · other public 20.75%
- Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment.Ordinary95.50% for4.50% against
Against: promoters 0.00% · institutions 25.30% · other public 0.21%
Turnout: all 53.16% · promoters 99.98% · institutions 40.52% · other public 20.75%
- Approval for Material Related Party Transaction(s) with Greenlife Pharmaceuticals LimitedOrdinaryPromoters have an interest in it63.17% for36.83% against
Against: promoters 0.00% · institutions 70.57% · other public 0.21%
Turnout: all 18.03% · promoters 0.00% · institutions 40.52% · other public 20.72%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 19 Sep 2026, 2 fund houses
- APPOINTMENT OF MR. SANTOSH PARAB (DIN: 01622988) AS A DIRECTOR IN THE CAPACITY OF NON-EXECUTIVE NON-INDEPENDENT DIRECTOR OF THE COMPANY.
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. No concern identified on the merits of proposed appointee. Governance concern: Cooling off period of 1-year not served for transition from ID to NED; appointment as NED raises question over appointee’s Independence as ID.
0 for2 against
Mutual fund votes, meeting of 15 Jul 2026, 2 fund houses
- Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026 together with the Reports of the Board of Directors and the Auditors
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundUnqualified financial statements. Non-Compliant with Companies Act, 2013 & SEBI LODR Regulations: The Company has not disclosed audited financial statements of subsidiaries for FY 2025-26 on its website of the Company.
0 for2 against - Declaration of Final Dividend of 100% i.e. ₹ 1.00 per equity share on face value of ₹ 1/- each for the financial year ended March 31, 2026.2 for0 against
- Re-Appointment of Mr. Narsimha Shibroor Kamath (DIN: 00140593) as a Managing Director & CEO, liable to retire by rotation, who has offered himself for re-appointment.
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. No concern on the merits of the proposed director. Governance Concern: Director holds 2 full time positions in Companies not engaged in related business and none of them hold substantial stake in the other company; hence excessive time commitments.
0 for2 against
Mutual fund votes, meeting of 9 May 2026, 2 fund houses
2 proposals
- APPOINTMENT OF MR. VIJAYANARAYANAN MAHADEVAN (DIN: 06639177) AS A DIRECTOR IN THE CAPACITY OF NON-EXECUTIVE AND INDEPENDENT DIRECTOR OF THE COMPANYFOR A TERM OF FIVE YEARS2 for0 against
- APPOINTMENT OF MR. DEEPAK RAMESHCHANDRA SHAH (DIN: 06954206) AS A DIRECTOR IN THECAPACITY OF NON-EXECUTIVE AND INDEPENDENT DIRECTOR OF THE COMPANYFOR A TERM OF FIVE YEARS2 for0 against
Mutual fund votes, meeting of 29 Jan 2026, 2 fund houses
1 proposal
- Appointment of Mr. Narsimha Shibroor Kamath (DIN:00140593) as ‘Director’ in the capacity of ‘Managing Director’ of the company.2 for0 against
Mutual fund votes, meeting of 31 Jul 2025, 2 fund houses
4 proposals
- Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2025 together with the Reports of the Board of Directors and the Auditors thereon2 for0 against
- Declaration of Final Dividend of 50 percent i.e. Rs. 0.50 paisa per equity share on face value of Rs. 1 each for the financial year ended March 31, 2025.2 for0 against
- Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment.2 for0 against
- Appointment of Messers. AVS & Associates, Company Secretaries as Secretarial Auditors of the Company.2 for0 against
Mutual fund votes, meeting of 11 Jun 2025, 2 fund houses
2 proposals
- Approval of the issuance of sweat equity shares to Mr. Gagan Harsh Sharma (DIN: 07939421), Managing Director of the Company
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Issuance of sweat equity proposed for performing duties in the ordinary course.
0 for2 against - Approval of the issuance of sweat equity shares to Mr. Vishal Vijay Rao, Vice-President of the Company
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Inadequate justification for proposed appointee; No clarity of role and responsibility w.r.t. the Ghana subsidiary.
0 for2 against
Mutual fund votes, meeting of 25 Jul 2024, 1 fund house
10 proposals
- Adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2024 together with the reports of the Board of Directors and the Auditors thereon.1 for0 against
- Declaration of Final Dividend of 50% i.e. Re. 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2024.1 for0 against
- Re-Appointment of Mrs. Shruti Vishal Rao (DIN: 00731501) as a Director, liable to retire by rotation, who has offered herself for reappointment1 for0 against
- Appointment of Dr. Nandkumar Kashinath Chodankar (DIN: 02736718) as an Independent Director of the Company
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundNo concern on merit of Director. Non-Compliant with SEBI LODR: Prior approval of shareholders not sought for continuation after attaining the age of 75 years. No specific justification for continuation.
0 for1 against - Re-appointment of Mr. Gagan Harsh Sharma (DIN: 07939421) as a Managing Director of the Company
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundCompliant with law. No concern on merit of Director. Governance concern: No absolute cap on variable pay. Gender biased remuneration.
0 for1 against - Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Whole-Time Director of the Company
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundCompliant with law. No concern on merit of Director. Governance concern: No absolute cap on variable pay.
0 for1 against - Re-appointment of Mrs. Shruti Vishal Rao (DIN: 00731501) as a Whole-Time Director of the Company
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundCompliant with law. No concern on merit of Director. Governance concern: No absolute cap on variable pay.
0 for1 against - Re-appointment of Ms. Shilpa Bhatia (DIN: 08695595) as an Independent Director of the Company1 for0 against
- Re-appointment of Mr. Vishal Vijay Rao as a VicePresident of the Company, a relative of Directors holding office or place of profit in the Company1 for0 against
- Approval for Material Related Party Transaction(s) with Greenlife Pharmaceuticals Limited
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundCompliant with Law. Governance Concern: Basis for Arm’s Length pricing not disclosed.
0 for1 against
Mutual fund votes, meeting of 19 Jul 2023, 1 fund house
4 proposals
- doption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon.
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundUnqualified statements. Non-Compliant with Companies Act, 2013 & SEBI LODR Regulations: Non-disclosure of financial statements of Subsidiaries on the website.
0 for1 against - Declaration of Final Dividend of 50% i.e. ₹ 0.50 paisa per equity share on face value of Rs. 1/- each for the financial year ended March 31, 2023.1 for0 against
- Re-appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible offered herself for re-appointment.1 for0 against
- Approval for Material Related Party Transaction(s) with Greenlife Pharmaceuticals Limited
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundNo concern on merit of proposed transactions. Technical Non-compliance with SEBI Circular: Omnibus approval of RPTs for a period of more than one year
0 for1 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines and tax disputes
Reported in the filing for the quarter to Sep 2026.
- Fine or penaltyBSE LimitedSince 25 May 2026
Penalty Imposed of Rs. 3,50,000/-
Non-compliance of Regulation 17(1) of SEBI (Listing Obligations and Disclosure Requirements ) Regulations, 2015, with the requirements pertaining to the composition of the Board. - Fine or penaltyBSE LimitedSince 25 May 2026
Penalty Imposed of Rs. 2,05,000/-
Non-compliance of Regulation 17(1) of SEBI (Listing Obligations and Disclosure Requirements ) Regulations, 2015, with the requirements pertaining to the composition of the Board. - Fine or penaltyEmployees Provident Fund OrganizationSince 11 Sep 2026
Penalty Imposed of Rs. 8/-
Penalty for delay in payment of Provident Fund - Fine or penaltyEmployees Provident Fund OrganizationSince 29 Jul 2026
Penalty Imposed of Rs. 665/-
Penalty for delay in payment - Tax disputeDeputy Commissioner of Income TaxSince 13 Dec 2016OGE passed for the AY 2014-15 with certain errors by Ld. Assessing officer. Rectification has been filed vide rectification letter dated 27.02.2026.At the filing before: Assessment Year 2014-15: Order giving effect to an Appealate order received on 22.09.2025
- Tax disputeAssistant Commissioner of Income Tax, Central Circle 7(1), MumbaiSince 6 May 2021
The company has opted for Direct Tax Vivad Se Vishwas Scheme, 2024 for the Assessment Year 2017-18 and filed Form 1 declaration dated 29.01.2025 on e-portal. Accepting application of Company, Form 4 has been issued by Hon'able Pr. CIT on 3rd April 2025. We have discharged additional Income tax liability as on 09.06.2025 as a secondary adjustment pursuant to adjustments u/s 92CA(3).The tax refund of Rs.71,83,523/- due to the company for the AY 2017-18 has been duly credited on 18-08-2026.MoreLess
At the filing before: Assessment Year 2017-18: An Appeal withdrawn by opting for settlement of dispute under DTVSV Scheme 2024. - Tax disputeAssistant Commissioner of Income Tax, Central Circle 7(1), MumbaiSince 22 Oct 2021
The company has opted for Direct Tax Vivad Se Vishwas Scheme, 2024 for the Assessment Year 2018-19 and filed Form 1 declaration dated 29.01.2025 on e-portal. Accepting application of Company, Form 4 has been issued by Hon'able Pr. CIT on 3rd April 2025. We have discharged additional Income tax liability as on 09.06.2025 as a secondary adjustment pursuant to adjustments u/s 92CA(3). The DTVSV tax refund of Rs.82,99,760/- due to the company for the AY 2018-19 has been wrongly adjusted against the demand liability of AY 2014-15 vide challan no.42874 dtd.31.12.2025. The company has filed rectification letter on 27.02.2026 to arrive at correct position of refund for the year under consideration.MoreLess
At the filing before: Assessment Year 2018-19: An Appeal withdrawn by opting for settlement of dispute under DTVSV Scheme 2024. - Tax disputeAssistant Commissioner of Income Tax, Central CircleSince 30 Mar 2025
On 15.04.2025 company uploaded its objection for reopening. We believed that since there is no escapement of income, assessment could not be reopened. However, the JAO has ordered the reopening of assessement. The company has filed entire submission to the notice u/s 142(1) of the Act on 07.07.2026MoreLess
At the filing before: The Company received notice dated 30-03-2025 u/s 148A for reopening of assessment u/s 147 for AY 2019-20.Subsequently, the Company received further notice dated 06-06-2026 u/s 142(1) of the Income Tax Act, 1961 for the same assesment year.MoreLess
11 more
- Tax disputeAssistant Commissioner of Income Tax, Central CircleSince 31 Mar 2026
The company has replied to the notice u/s 148A of the act on 06.04.2026.On 09-06-2026, AO has passed order u/s 148A(3) for reopening the assessment on the grounds that deduction u/s 80G with respect to CSR-funded donations amounting to Rs.1,02,50,000/- wrongly allowed in the assessment.MoreLess
At the filing before: The company has received show cause notice for proceedings u/s 148A of the income tax act dtd.31.03.2026 for the AY 2020-21. - Tax disputeAssistant Commissioner of Income Tax, Central Circle 7(1), MumbaiSince 7 Jul 2025
There is an addition of Rs.1.50 lakhs in the final assessment order. However, the Assessing officer has erred in passing order by not allowing certain legitimates deductions. Due to which wrong demand of Rs.23,50,980/- has been outstanding on IT portal. The rectification has been filed by the company on 18.03.2026.The Rectification order u/s 154 of the Income‑tax Act, 1961 was passed on 13.08.2026 and communicated on 08.09.2026, rectified in accordance with the company’s contentions allowing the deductions which was earlier erred in demand computation sheet. However, assessing officer has raised penalty demand of Rs.1,04,832/- u/s 270A of the Income Tax Act,1961.MoreLess
At the filing before: Assessment Year 2024-25:Assessment proceedings concluded and final order u/s 143(3) of the Income tax Act received on 14-03-2026. - Tax disputeIncome Tax Officer, TDS Circle 1(1), MumbaiSince 26 Jun 2024The notice has been received dtd.03.09.2026 for outstanding demand on Traces Portal. An adjournment has been taken for modifications and corrections on traces portal vide letter dtd.11.09.2026.
At the filing before: Company has compiled data yearwise by tagging appropriate lower deduction certificates against demand raised due to shortfall in TDS deduction as well as done required rectifications on traces portal to delete demand raised on account of Inoperative PAN of the employees.MoreLess
- Tax disputeThe Assistant Commissioner, Central Excise & Central GST, Division VII, Mumbai East CommissionerateSince 30 Aug 2024The Writ Petition has filed before Hon'ble Bombay High Court and the next date of hearing is scheduled for 26th Oct, 2026.
At the filing before: The refund application was rejected by The Asst. Commissioner of CGST. Subsequently an Appeal was filed before Commissioner (Appeals-II) Mumbai against rejection order. The appellate authority upheld the order passed by the Asst. Commissioner of CGST and dismissed the appeal vide O-I-A No. 474/VKP/ADC/APPEALS-II/ME/24-25 Dated 27/02/2025.MoreLess
- Tax disputeUnion of India & OthersSince 9 Oct 2023Writ Petition filed before Hon'ble Bombay High Court.
At the filing before: Rebate applications rejected by The Asst. Commissioner, Rebate, O-I-O is upheld by Commissioner (Appeals), Mumbai, and The Principal Commissioner & Ex. Officio, Additional Secretary, The Govt., of India, Revisional Authority.MoreLess
- Tax disputeUnion of India & OthersSince 18 Jul 2024Writ Petition filed before Hon'ble Bombay High Court.
At the filing before: Additional Commissioner of Central Excise, Raigad, issued Show Cause cum-demand Notices to recover sanctioned rebate. These demands were confirmed by The Joint Commissioner but subsequently set aside by the Commissioner (Appeals). Thereafter Dept. filed Revision Application to the RA Authority (GOI) which upheld the demand raised in the original Cause cum -demand Notices issued by Additional Commissioner.MoreLess
- Tax disputeUnion of India & OthersSince 31 Oct 2018Writ Petition filed before Hon'ble Bombay High Court.At the filing before: Deputy Commissioner, C. E. rejected refund application, after which Commissioner (Appeals) and CESTAT also upheld order issued by Dy. Commissioner.
- Tax disputeJoint Commissioner of CGST and Central Excise, Mumbai East, MumbaiSince 30 Jun 2025
Hon'ble Supreme Court has upheld the Judgement of Bomby High Court wherein Hon'ble Bombay High Court had held that all the proceedings in respect of Omission of Rule 96(10) shall stand dispossed off and the said judgement of Hon,ble Supreme Court has been accepted by CBIC by issuing Office Menorandum dated 24th Aug 2026.MoreLess
At the filing before: Joint Commissioner of CGST and Central Excise, Mumbai East, Mumbai has issued Show Cause Notice with regards to availing IGST Refund on exports in contravention of Rule 96(10) of the CGST Rules, 2017 during FY 2018-19.MoreLess
- Tax disputeJoint Commissioner of CGST and Central Excise, Mumbai East, MumbaiSince 30 Sep 2025
Hon'ble Supreme Court has upheld the Judgement of Bomby High Court wherein Hon'ble Bombay High Court had held that all the proceedings in respect of Omission of Rule 96(10) shall stand dispossed off and the said judgement of Hon'ble Supreme Court has been accepted by CBIC by issuing Office Memorandum dated 24th Aug 2026.MoreLess
At the filing before: Joint Commissioner of CGST and Central Excise, Mumbai East, Mumbai has issued Show Cause Notice with regards to availing IGST Refund on exports in contravention of Rule 96(10) of the CGST Rules, 2017 during the FY 2019-20 to 2023-24.MoreLess
- Tax disputeAsst. Commissioner of State Tax, Mazgaon, MumbaiSince 6 Nov 2025We appeared before Asst. Commissioner of State Tax and submitted required documents, awaiting for further proceedings / Order.
At the filing before: Asst. Commissioner of State Tax, Mazgaon, Mumbai has issued Summons to appear along with details of; i. Payment realization details (FIRC, BRC) of export invoices for which refund had been claimed for the F.Y. 2023-24 & 2024-25. ii. ITC register (Annexure-B) in respect of refund claimed for the F.Y. 2023-24 & 2024-25. iii. Sample copy of export invoices and purchase invoices.MoreLess
- Tax disputeSuperintendent of CGST, Range:I, Div:VII, Vadodara-I CommissionerateSince 15 May 2026We have filed reply in Form GST ASMT-11 to the subject Notice and are in receipt of closure order in Form GST ASMT-12.
At the filing before: GST Jurisdictional Authorities, Vadodara issued Return discrepancy Notice in Form GST ASMT-10 for FY 2022-23. As per Notice, we have availed excess ITC in Form GSTR3B than the same available as per Form GSTR2B for the same tax period.MoreLess
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.